Previous close | 0.0400 |
Open | 0.0800 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 95.00 |
Expiry date | 2024-04-19 |
Day's range | 0.0400 - 0.1800 |
Contract range | N/A |
Volume | |
Open interest | 3.22k |
China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters.
In the latest trading session, Moderna (MRNA) closed at $103.44, marking a -0.34% move from the previous day.
Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.